ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FUM Futura Medical Plc

35.65
0.15 (0.42%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 0.42% 35.65 35.40 35.90 36.50 34.05 36.50 425,707 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -18.25 106.45M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 35.50p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £106.45 million. Futura Medical has a price to earnings ratio (PE ratio) of -18.25.

Futura Medical Share Discussion Threads

Showing 14251 to 14258 of 21425 messages
Chat Pages: Latest  581  580  579  578  577  576  575  574  573  572  571  570  Older
DateSubjectAuthorDiscuss
07/11/2022
10:42
..........................ITS THE LBO SHOW .........................................
mikethebike4
06/11/2022
08:40
Petroc is a proven ramper who is also now trying to claim he is a more reliable source then the courts, the ASA and FTC rulings. It has been repeatedly proven he is only relying on ‘deficient evidence’ from a subjective and vested interest which gives all the necessary disclaimers. Yet he continues to repeatedly post false and misleading claims that he cannot substantiate. The ASA, FTC and the Courts are all reliable sources of information and rely on all the objective evidence and the opinion of the wider scientific and academic community. While the rampers false and unsubstantiated claims with zero disclaimers just keep confirming they are trying to just ‘swindle’ the naive into only hear their ramping lies and get them
to buy shares so the rampers can sell out at their expense. That is the definition of a ramper like Petroc engaging in illegal
market manipulation.



Remember, the anonymity of the Internet should make you skeptical of what anyone says if you don’t know who they are. Before making a buy or sell decision on a stock, make sure you are dealing with a reliable source. And if that source is an anonymous stock forum poster, that source is rarely reliable.

Here are 15 ways you can identify the stock discussion board ramper. I’ve seen the same behaviors in the stock rampers across many stock forums. Once you know the warning signs, you can learn to spot the ramper much more easily: They attack those who disagree with their lofty predictions. They cannot back up their arguments with a rational discussion, so they resort to petty name calling and telling others who disagree with them that they are ‘full of it’

lbo
05/11/2022
12:11
Higher, LiarBO! Higher! Hehehe!
petroc
05/11/2022
11:38
Its also all a feeble attempt at deflecting from the fact that Med3000 still has no enforceable patent either. If anyone can even be able to enforce a patent on a placebo effect! LOL

Even Dermasys on its own has no patent anymore. Its just a trademark name now. And even the Dermasys trademark predates by many years the umbrella patents covering MED2005 (Dermasys and GTN) and TPR100 (Dermasys and Diclofenac) which are all expiring soon also.

from Trinity in a previous note regarding the MED2005 patent:

‘long development period resulted in a material erosion of the patent life, with the original formulation patent expected to expire in 2025’

Dermasys is even older then Med2005 so is off patent now

2002 plus 20 years = 2022




GlaxoSmithKline unexpectedly handed back the development rights to Futuras erectile dysfunction gel. We are not going to progress on this particular compound for normal commercial reasons which we do not wish to go into, GSK said.



The cooling effect of a topically applied product can be evaluated using a validated handheld thermal imaging system. When the gel matrix is destroyed after application to the skin, the bound water and alcohol evaporates and a measurable cooling-effect results.




The DermaSys(R) technology was originally developed by Futura for use in the Company's topical treatment for erectile dysfunction, MED2002





Under the terms of the agreement, Thornton & Ross will conduct the manufacturing scale-up of TPR100 and hold rights to manufacture, market and distribute the product in the UK for the lifetime of the product's patents, which run to at least 2028 in the UK

lbo
05/11/2022
11:32
Petroc is a proven liar using Multi-IDs all over the internet to try pump Futura. He lied when he said the evaporative cooling effect of Dermasys could not be replicated. The ramping liars can try childish tactics to deflect but cannot filter the facts that have repeatedly proven to be liars! LOLpetroc - 20 Feb 2020 - 10:14:36PDT, as Dermasys has been Futura's core product for several years, and upon which they base their marketing strategy, I very much doubt that it's easy to replicate faithfully or legally. Besides, there are many "wonder creams" out there that claim to do the job,(a friend tells me), and yet research still continues for something that actually does.https://www.pharma-mkting.com/blog/no-goopy-ed-gel-in-gsks-futura/We are not going to progress on this particular compound for normal commercial reasons which we do not wish to go into, GSK saidhttps://www.gskhealthpartner.com/content/dam/cf-consumer-healthcare/health-professionals/en_IN/pdf/article-1.pdfThe cooling effect of a topically applied product can be evaluated using a validated handheld thermal imaging system. When the gel matrix is destroyed after application to the skin, the bound water and alcohol evaporates and a measurable cooling-effect results.Voltaren vehicle gel application resulted in a rapid reduction of skin surface temperature by 5.1°C after only 3 minhttps://www.edisoninvestmentresearch.com/?ACT=18&ID=10479There is a risk that some claims will either be challenged in future (eg on the grounds of non-obviousness or existence of prior art) and/or that another technology may be employed to achieve a similar effect. The protracted development times mean the clock has been ticking on the original issued patents, reducing the protected commercial product
lbo
05/11/2022
11:20
The only jumping being done is by the rampers. You jumped on the bandwagon of trying to swindle others! Now you are so desperate to try jump off the sinking ship of lies you have to just keep telling more and more lies to desperately keep it afloat! Pure comedy watching it unfold! ROFLMAO



Proof is what separates an effect new to science from a swindle . . . . If a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the consumer. FTC v. QT, Inc., 512 F.3d 858, 862-63 (7th Cir.

Trinity Research even openly admitted the hypothesised effects ‘˜believed’ to be happening by Futura are ‘disputed’. Trinity admitted no mechanism of action has to be even shown to get a medical device approved. But it does need to be proven to substantiate its marketing claims or fall foul of the FTC, ASA and the Courts.

Trinity research:

Presumably the effect is comparable to the cold-induced vasodilation (CIVD) that occurs with extremities such as toes and fingers. Despite being a well-known effect, the mechanisms of CIVD are still disputed, but the pathways involved could well be similar. Interestingly, the precise mechanism of action does not need to be elucidated for the regulators to be comfortable for a product to be approved as medical device



There is no evidence for the evaporative mode of action from the clinical trials. To show that the evaporation is what makes MED3000 work, you'd need to compare it to a non-evaporative gel.

lbo
05/11/2022
11:14
Heheheh! Jump, LiarBO, jump!
petroc
04/11/2022
20:50
Oh dear, LiarBO! Thank you for confirming what I just said! 'The rulings are clear and were about other other medical devices'. Yes, exactly what I just posted. Why don't you try and find actual evidence that MED3000 doesn't work? We know why, of course. There isn't any. Good luck!
petroc
Chat Pages: Latest  581  580  579  578  577  576  575  574  573  572  571  570  Older

Your Recent History

Delayed Upgrade Clock